Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Dilated Cardiomyopathy Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Dilated cardiomyopathy (DCM) is a disorder in which the heart enlarges and becomes unable to pump blood properly. Other organs, such as the lungs, liver, and kidney, may suffer as a result of the lower heart function. The heart muscles begin to dilate (stretch), resulting in the chamber becoming thinner and larger, and spreading to the right ventricle and atria. Heart muscles do not contract normally as the heart chambers dilate, and they are unable to pump blood normally. In addition, the heart gets weak, which can lead to cardiac failure. Fatigue, edoema in the ankles, legs, and feet, and varicose veins in the neck and belly are all common signs of heart failure.

 

Rise in congestive heart failure fuels the growth of dilated cardiomyopathy market

There has been an increase in the number of people diagnosed with congestive heart failure, which has resulted in an increase in the number of people diagnosed with dilated cardiomyopathy. According to the American Heart Association, over 5.7 million persons in the United States suffered from heart failure in 2016. However, the FDA has not approved any drugs to treat dilated cardiomyopathy. In addition, firms are investing in the research and development of novel medications like ARRY-797 and Ixmyelocel-T, which are likely to help the dilated cardiomyopathy market grow. Increased usage of defibrillators, pacemakers, and a shortage of appropriate medications are all major difficulties for the DCM industry.

 

Dilated Cardiomyopathy Market
Dilated Cardiomyopathy Market

Developed regions are major growth engine of dilated cardiomyopathy market

North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa make up the dilated cardiomyopathy market. Due to an increase in congestive heart failure cases, the DCM market in North America has seen tremendous expansion. According to the European Heart Network's 2017 estimate, there are around 3.9 million deaths caused by cardiovascular disease in Europe, with over 1.8 million deaths in the European Union. The Asia Pacific market is the third largest and is predicted to develop at a faster rate as a result of growing awareness of cardiovascular disease and need for generic medications, which will help the DCM market grow.

 

 

 

Key players of dilated cardiomyopathy market

The DCM market has a number of participants from all around the world who contribute to the market. Pfizer Inc., Johnson & Johnson Pvt. Ltd., Array BioPharma, AstraZeneca, GlaxoSmithKline Plc., and Sanofi are some of the major participants.

 

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027